vinflunine,docetaxel,erdafitinib,pembrolizumab
pierre fabre,merck,janssen
['bladder', 'thor study', 'janssen']
through the development of innovative targeted therapies, we aim to address unmet needs in the treatment of #bladdercancer. we re sharing our latest data from the phase 3 thor study at #asco23: 
At Janssen, we never stop working toward a future where disease is a thing of the past. Channel run by Janssen Global Services LLC, NJ, USA.